Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now shows “TypeError: Failed to fetch” instead of a 403 Forbidden response, and the NIH transition notice is no longer displayed.
    Difference
    1%
    Check dated 2026-11-09T13:50:33.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T15:45:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the inaccessible study record.
    Difference
    1%
    Check dated 2026-10-26T14:18:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:16:43.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:57.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a simple header and a Home button, indicating access is blocked. As a result, the study details that would normally appear on the page are not accessible.
    Difference
    20%
    Check dated 2026-09-21T20:24:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.